Development and validation of the comprehensive assessment scale for chemotherapy–induced peripheral neuropathy in survivors of cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development and validation of the comprehensive assessment scale for chemotherapy–induced peripheral neuropathy in survivors of cancer
Authors
Keywords
Cancer survivors, CIPN, Scale, PRO, Comprehensive assessment, Measurement, Symptom, QOL
Journal
BMC CANCER
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-10
DOI
10.1186/s12885-019-6113-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk
- (2016) Ting Bao et al. BREAST CANCER RESEARCH AND TREATMENT
- The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling
- (2016) Noah A. Kolb et al. JAMA Neurology
- Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives
- (2015) Marianne Ewertz et al. ACTA ONCOLOGICA
- Uncertainty, Self-efficacy, and Self-care Behavior in Patients With Breast Cancer Undergoing Chemotherapy in China
- (2015) Yingzi Zhang et al. CANCER NURSING
- Validity of the Chemotherapy-induced Peripheral Neuropathy Self-Check Sheet
- (2015) Yumiko Miyoshi et al. INTERNAL MEDICINE
- Chemotherapy-induced neuropathy: A comprehensive survey
- (2014) N.C. Miltenburg et al. CANCER TREATMENT REVIEWS
- Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
- (2014) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
- (2014) Marta Seretny et al. PAIN
- A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration
- (2014) A. J. M. Beijers et al. SUPPORTIVE CARE IN CANCER
- Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review
- (2014) Floortje Mols et al. SUPPORTIVE CARE IN CANCER
- Chemotherapy-induced peripheral neurotoxicity: A critical analysis
- (2013) Susanna B. Park et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Short-Term Projection of Cancer Incidence in Japan Using an Age-Period Interaction Model with Spline Smoothing
- (2013) K. Katanoda et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire
- (2013) Ellen M. Lavoie Smith et al. QUALITY OF LIFE RESEARCH
- Chemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence
- (2011) David Balayssac et al. Expert Opinion On Drug Safety
- Discrepancy between the NCI-CTCAE and DEB-NTC scales in the evaluation of oxaliplatin-related neurotoxicity in patients with metastatic colorectal cancer
- (2011) Naohiko Inoue et al. International Journal of Clinical Oncology
- Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy
- (2010) Dawn L. Hershman et al. BREAST CANCER RESEARCH AND TREATMENT
- Surviving Chemotherapy for Colon Cancer and Living with the Consequences
- (2010) Cindy Tofthagen JOURNAL OF PALLIATIVE MEDICINE
- Measures of chemotherapy-induced peripheral neuropathy: a systematic review of psychometric properties
- (2010) Kathleen A. Griffith et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline
- (2009) Paul G. Richardson et al. BRITISH JOURNAL OF HAEMATOLOGY
- Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02
- (2009) Kojiro Shimozuma et al. SUPPORTIVE CARE IN CANCER
- Symptom Prevalence and Longitudinal Follow-Up in Cancer Outpatients Receiving Chemotherapy
- (2008) Akemi Yamagishi et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More